BRAINSTORM CELL THERAPEUTICS INC.
1325 Avenue of Americas 28th Floor
New York, NY 10019
| August 28, 2019 |
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Suzanne Hayes
| RE: |
Brainstorm Cell Therapeutics Inc. Registration Statement on Form S-3 Filed August 16, 2019 File No. 333-233349 Acceleration Request |
Ladies and Gentlemen:
Pursuant to Rule 461 of the Rules and Regulations promulgated under the Securities Act of 1933, as amended, Brainstorm Cell Therapeutics Inc. (the “Company”) hereby respectfully requests that the effectiveness of the above-captioned Registration Statement on Form S-3 be accelerated to Friday, August 30, 2019, at 4:00 p.m. Eastern Time, or as soon as practicable thereafter.
Any questions regarding this request should be addressed to Thomas B. Rosedale, Esq., at BRL Law Group LLC at (617) 399-6931.
|
Very truly yours,
Brainstorm Cell Therapeutics Inc.
/s/ Chaim Lebovits By: Chaim Lebovits Its: President and Chief Executive Officer |
| cc: | Thomas B. Rosedale, Esq. |
(BRL Law Group LLC)